We have previously shown that TP53 wild-type breast cancer cells survive chemotherapy by entering a senescent state that arrests the cell cycle to prevent mitotic catastrophe [4,5] and blocks apoptosis by activity of BCL-XL and/or MCL1 [6,7]. Here, TP53 is linked to breast cancer.